Pinnow Cole
SEC insider (Form 3/4/5 filer). CIK 0002024135. Chief Commercial Officer at Cogent Biosciences, Inc. (COGT). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in WALTHAM, MA.
Companies Pinnow Cole has filed insider reports for
- Cogent Biosciences, Inc. (COGT): Officer, Chief Commercial Officer
Pinnow Cole
CIK: 0002024135
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COGT
Cogent Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Dec 17, 2025COGT
Cogent Biosciences, Inc.
AwardDirect50K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
AwardDirect214K shares- - Dec 17, 2025COGT
Cogent Biosciences, Inc.
Tax PaymentDirect94.8K shares at avg. $39.45$3.7M - Jan 23, 2025COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
240K shares- - Jan 14, 2025COGT
Cogent Biosciences, Inc.
PurchaseDirect43.8K shares at avg. $7.60$332K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award | 50,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Award | 214,000 | - | - | Direct |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | Tax Payment | 94,800 | $39.45 | $3,739,860 | Direct |
| Jan 23, 2025 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 240,000 | - | - | Direct |
| Jan 14, 2025 | COGT Cogent Biosciences, Inc. | Purchase | 43,750 | $7.60 | $332,413 | Direct |
1-5 of 5 transactions